Philadelphia-based medical technology company Impilo has successfully closed an $11.5 million Series A funding round, led by Washington D.C.’s Construct Capital, with participation from GC 1 Capital, Boston’s One Way Ventures, Princeton’s 2048 Ventures, and several angel investors.
Founded in 2020, Impilo specializes in developing digital healthcare infrastructure that enables medical service providers to deliver diagnostic services and patient care remotely. The company’s innovative technology allows patients to receive high-quality healthcare from the comfort of their homes through advanced remote sensors and monitoring devices.
Impilo operates on a unique 4PL (Fourth-Party Logistics) model, where a single external service provider manages the entire supply chain and logistics process for healthcare delivery.
“This funding is a game-changer for us,” said Impilo founder and CEO Josh Stein. “It will allow us to supercharge our growth, expand our footprint across the provider and payer sectors, and continue to innovate on a platform that makes high-quality healthcare more accessible than ever.”
Funding Highlights:
- Total Funding: $11.5 million
- Funding Round: Series A
- Lead Investor: Construct Capital
- Co-Investors: GC 1 Capital, One Way Ventures, 2048 Ventures
About Impilo:
- Founded: 2020
- Headquarters: Philadelphia
- Core Business: Digital Healthcare Infrastructure, Remote Medical Solutions
The funds will be primarily used for technology research and development, business expansion, and team building, further advancing Impilo’s strategic positioning in the digital healthcare sector.
News Source:citybiz，This article does not represent our position.
